Key Benefits

• Long half-life offering once-daily dosing convenience for most patients
  
  
• Well characterized tolerability profile
  
  
• The long-term use of ceftriaxone has not been associated with an increase in resistance. High level resistance remains rare
  
  
• Suitable for intramuscular and well as intravenous use
  
  
• Empirical therapy against susceptible organisms in meningitis
  
  
• Important place in the treatment of invasive pneumococcal infections, including those with reduced ß-lactam susceptibility
  
  
• Important role in the management of AOM, especially when S. pneumoniae is suspected

Indications

• Pneumonia
  
  
• Septicaemia
  
  
• Meningitis
  
  
• Bone, skin and soft tissue infections
  
  
• Infections in neutropenic patients
  
  
• Gonorrhoea
  
  
• Peri-operative prophylaxis of infections associated with surgery
  
  
• Treatment may be started before the results of susceptibility tests are known